NLS Pharmaceutics AG
General ticker "NLSP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $303.8K (TTM average)
NLS Pharmaceutics AG follows the US Stock Market performance with the rate: 7.2%.
Estimated limits based on current volatility of 11.9%: low 7.66$, high 9.73$
Factors to consider:
- Total employees count: 200000 (0.0%) as of 2024
Short-term NLSP quotes
Long-term NLSP plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $11.81MM | $4.38MM |
| Operating Income | $-11.81MM | $-4.38MM |
| Non-Operating Income | $-0.36MM | $2.40MM |
| Interest Expense | $0.15MM | $0.15MM |
| R&D Expense | $5.91MM | $0.42MM |
| Income(Loss) | $-12.17MM | $-1.98MM |
| Profit(Loss)* | $-12.17MM | $-1.98MM |
| Stockholders Equity | $-8.83MM | $1.41MM |
| Assets | $1.85MM | $2.23MM |
| Operating Cash Flow | $-9.68MM | $-4.27MM |
| Capital expenditure | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-0.00MM |
| Financing Cash Flow | $1.63MM | $5.04MM |
| Earnings Per Share** | $-3.19 | $-26.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.